Annual Cash & Cash Equivalents
$111.27 M
-$48.25 M-30.25%
31 December 2023
Summary:
Repare Therapeutics annual cash & cash equivalents is currently $111.27 million, with the most recent change of -$48.25 million (-30.25%) on 31 December 2023. During the last 3 years, it has fallen by -$214.92 million (-65.89%). RPTX annual cash & cash equivalents is now -66.73% below its all-time high of $334.43 million, reached on 31 December 2021.RPTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$80.54 M
+$721.00 K+0.90%
30 September 2024
Summary:
Repare Therapeutics quarterly cash and cash equivalents is currently $80.54 million, with the most recent change of +$721.00 thousand (+0.90%) on 30 September 2024. Over the past year, it has dropped by -$26.83 million (-24.99%). RPTX quarterly cash and cash equivalents is now -78.23% below its all-time high of $369.93 million, reached on 30 June 2020.RPTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPTX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.3% | -25.0% |
| 3 y3 years | -65.9% | -69.1% |
| 5 y5 years | +936.9% | - |
RPTX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -66.7% | at low | -75.9% | +0.9% |
| 5 y | 5 years | -66.7% | +936.9% | -78.2% | +0.9% |
| alltime | all time | -66.7% | +936.9% | -78.2% | +0.9% |
Repare Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $80.54 M(+0.9%) |
| June 2024 | - | $79.82 M(-22.7%) |
| Mar 2024 | - | $103.22 M(-7.2%) |
| Dec 2023 | $111.27 M(-30.2%) | $111.27 M(+3.6%) |
| Sept 2023 | - | $107.37 M(-7.1%) |
| June 2023 | - | $115.54 M(-4.9%) |
| Mar 2023 | - | $121.46 M(-23.9%) |
| Dec 2022 | $159.52 M | $159.52 M(+2.8%) |
| Sept 2022 | - | $155.19 M(-43.7%) |
| June 2022 | - | $275.83 M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $305.14 M(-8.8%) |
| Dec 2021 | $334.43 M(+2.5%) | $334.43 M(+28.1%) |
| Sept 2021 | - | $261.00 M(-11.1%) |
| June 2021 | - | $293.63 M(-5.7%) |
| Mar 2021 | - | $311.40 M(-4.5%) |
| Dec 2020 | $326.18 M(+244.1%) | $326.18 M(-6.2%) |
| Sept 2020 | - | $347.87 M(-6.0%) |
| June 2020 | - | $369.93 M(+341.9%) |
| Mar 2020 | - | $83.71 M(-11.7%) |
| Dec 2019 | $94.80 M(+783.4%) | $94.80 M |
| Dec 2018 | $10.73 M | - |
FAQ
- What is Repare Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Repare Therapeutics?
- What is Repare Therapeutics annual cash & cash equivalents year-on-year change?
- What is Repare Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Repare Therapeutics?
- What is Repare Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Repare Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of RPTX is $111.27 M
What is the all time high annual cash & cash equivalents for Repare Therapeutics?
Repare Therapeutics all-time high annual cash & cash equivalents is $334.43 M
What is Repare Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, RPTX annual cash & cash equivalents has changed by -$48.25 M (-30.25%)
What is Repare Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RPTX is $80.54 M
What is the all time high quarterly cash and cash equivalents for Repare Therapeutics?
Repare Therapeutics all-time high quarterly cash and cash equivalents is $369.93 M
What is Repare Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, RPTX quarterly cash and cash equivalents has changed by -$26.83 M (-24.99%)